Stage FocusSeries B+
GeographyUS, Europe
TypeFamily Office
Last Activity2025
Industry Focus
Industries
AI
Technical BenchLimited
Investor TypeGeneralist
ExposureSome DeepTech Investments
Bio
Lingotto is the investment management arm of Exor N.V., the Agnelli family holding company, managing $9.8B in AUM including commitments as of September 2025. FCA-regulated and London-based, the firm runs multiple strategies: Intersection, Horizon, Innovation, and Mosaic.
The portfolio includes 70 positions per the latest 13F filing. The philosophy embraces concentration, illiquidity, and volatili...
Similar Funds
Acton Capital
Munich, Germany
GeneralistAIMedtechMobilitySeries ASeries B+
Adobe Ventures
San Jose, United States
GeneralistAISeedSeries A
Advent International
Boston, United States
GeneralistAIMedtechSeries B+
Allianz X
Munich, Germany
GeneralistAIMedtechBlockchainSeries B+
Atlassian Ventures
Sydney, Australia
GeneralistAICybersecuritySeedSeries A
Battery Ventures
Boston, United States
GeneralistAIIoT & EdgeCybersecuritySeedSeries A